Predictive Biomarkers of Response to Immunotherapy in Metastatic Renal Cell Cancer

Predictive Biomarkers of Response to Immunotherapy in Metastatic Renal Cell Cancer

IntroductionIn the last decades, the therapeutic decision-making approach to metastatic renal cell cancer (mRCC) has dramatically changed thanks to the introduction in the treatment scenario of, first, anti-angiogenic agents and, afterward, immune-checkpoint inhibitors (ICIs). Immunotherapy is now t...

Full description

Bibliographic Details
Main Authors: Alessandra Raimondi, Pierangela Sepe, Emma Zattarin, Alessia Mennitto, Marco Stellato, Melanie Claps, Valentina Guadalupi, Elena Verzoni, Filippo de Braud, Giuseppe Procopio
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-08-01
Series:Frontiers in Oncology
Subjects:
biomarker
immunotherapy
metastases
PD-L1
renal cell carcinoma
tumor mutational burden
Online Access:https://www.frontiersin.org/article/10.3389/fonc.2020.01644/full

Internet

https://www.frontiersin.org/article/10.3389/fonc.2020.01644/full

Similar Items